Seminars / CE
Any qualified self-study continuing education (CE) hours obtained while Indiana is under the public health emergency may be applied toward the 40-hour requirement for the licensure period ending on April 1, 2022. The Indiana Optometry Board (IOB) clarified its waiver of the 8-hour limit on November 4, 2020. The IOB also voted to request a waiver of the post-examination requirement from Governor Holcomb. The post examination requirement for self-study hours remains in place until a waiver on the exam requirement is approved by the Governor. IOA will notify members if the additional waiver is granted.
Under Indiana law, self-study includes live streamed and static online CE courses. To be qualified, CE must be sponsored by an approved organization, such as IOA, COPE, a university, or the program must be specifically approved by the Indiana Optometry Board. Governor Holcomb declared a public health emergency due to COVID-19 on March 19, 2020. He has renewed his declaration in thirty day increments shortly after the initial declaration was made. The current declaration expires on April 30, 2021. Governor Holcomb will announce whether it will be renewed.
This course covers the anterior segment complications associated with herpes simplex virus infection. The natural history of the herpes simplex virus and the epidemiology of HSV infections are discussed. Blepharocunjunctivitis, dendritic keratitis, stromal keratitis, endothelitis, trabeculitis, iritis, and neurotrophic keratitis are all covered in detail. Primary disease vs. secondary recurrent disease is stressed.
This course covers injection techniques utilized by optometrists. Subcutaneous / intralesional, intramuscular, and intravenous injections are covered in detail. Proper sterile preparation techniques are discussed as well. An emphasis is placed upon learning the proper techniques associated with performing various types of injection procedures, and on their clinical uses. The pharmacology of injectable medications is also covered, as are several specific injectables.
Differentiating true papilledema from pseudopapilledema can be challenging, but the distinction is crucial. Properly making this important differential diagnosis can literally have life and death consequences. This course outlines the mechanisms for clinically distinguishing between the two entities. It covers papilledema and its systemic associations in detail, as well as optic nerve drusen, which is the number one cause of pseudopapilledema.
Online CE: Pain Management, Identification of Addiction, Practices of Prescribing, and Dispensing of Opioids
This two hour course meets the April 1, 2022 Indiana renewal requirement that all optometrists who hold or apply for a controlled substances registration after July 1, 2019 must have completed two hours of continuing education during the previous two years addressing the topic of opioid prescribing and opioid abuse. All optometrists may take the course to meet the requirements for Legend Drug Certificate and license renewal.
This course covers pharmaceuticals used in eye care, including many classes of topical ophthalmic medications and oral medications with ocular indications for use. It also covers the ocular side effects of many oral medications.
This course covers the diagnosis and management of many different types of anterior segment trauma. The proper assessment and care of conditions such as hyphema, chemical burns, corneal abrasions, foreign bodies, orbital blow out fractures, traumatic iritis, and corneal lacerations are discussed.
This course covers the diagnosis and management of several non-diabetic retinal vascular diseases. An emphasis is placed on systemic associations as well as clinical management. Conditions covered include ocular ischemic syndrome, hypertensive retinopathy, sickle cell retinopathy, Eale’s disease, Coat’s disease, retinal artery occlusions, retinal vein occlusions, and others.
This course covers the common oral medications prescribed by eye care practitioners including antibiotics, antivirals, pain medications and steroids. Emphasis is placed upon both pharmacological principals, and helping OD’s to get comfortable with the clinical use and prescribing of each category of medication.
This course qualifies for 2 hours of IOB CE Credit. Indiana OPTOMETRY has prepared this course to help practitioners to meet the requirements for license renewal. This course provides an overview of federal and Indiana statutes and rules that govern the practice of Optometry in Indiana.
Learn about the epidemiology and principles of systemic cancer, with details about ocular malignancies, including the differential diagnosis and management.
Virtual/Online CE: Swollen Optic Nerves & IPL Therapy in Optometric Practices
In part 1, this course covers optic nerve head pathology including swelling can range from very benign that only requires monitoring all the way to a life threatening emergency. In part 2, Dr. Lighthizer discusses Intense Pulsed Light Therapy which is a longstanding treatment in the dermatologic work for many skin conditions. Accidentally it was discovered to have ocular benefits as well. Over the past 2-3 years, it has become an emerging treatment for numerous ocular conditions including dry eye, meibomian gland dysfunction, ocular rosacea, chalazion, among other conditions.
Genetic testing in AMD is very controversial, especially as it relates to a potential positive or negative effect of high dose zinc supplementation. This course covers genetic testing in patients with AMD, and the research that has gotten us to this point. It discusses how genetic testing can be utilized in the office when caring for patients with AMD. In addition, OCT findings that lead to an increased risk of AMD progression are also covered.
Several states allow properly trained optometrists to perform certain anterior segment laser procedures, one of which is YAG posterior capsulotomy. This course covers all facets of YAG laser capsulotomy. The formation of posterior capsule opacification, indications for YAG capsulotomy, and contraindications for the procedure are all covered. In addition, the performance of the procedure is covered in detail, as are potential complications and post-operative care.
This is a recording of a virtual course that was presented on January 21, 2021.
This course utilizes a number of patient case encounters to highlight varied and unusual pathological conditions. Disease processes discussed include toxocariasis, choroidal folds, Lebers hereditary optic neuropathy, multiple idiopathic pigment epithelial detachment syndrome, Doynes honeycomb dystrophy, emulsified silicone oil, and iris melanoma.
This is a recording of a virtual course that was presented on February 1, 2021.This course covers administration of the COVID-19 vaccine in detail. The development of the currently approved vaccines, operation Warp Speed, and the delivery of intramuscular injections are all discussed. Specific information regarding delivery of the vaccines in an office setting is provided, as well as information regarding side effects, documentation, and follow-up administration. The science behind mRNA vaccines is discussed, as are the similarities and differences between the currently approved COVID-19 vaccines. Course Instructors: Anna Bedwell, OD, Larissa Krenk, OD, and Brad Sutton, OD This course is free to members of the IOA.
This is a recording of a virtual course that was presented on January 12, 2021. When it comes to the treatment of ocular conditions, optometrists do not tend to hesitate when prescribing topical medications but often hesitate in prescribing oral medications. This course examines the use of oral pharmaceuticals in the treatment/management of a variety of anterior segment diseases. This course is eligible for 2 hours of IOB and Legend Drug Credit. Course Instructor: Blair Lonsberry, OD
This is a recording of a virtual course that was presented on January 26, 2021. Ocular pain is an important reason why patients seek care, especially on an emergent basis. This presentation uses a case based approach to explore the most effective means to manage pain in optometric practice including the importance of understanding addiction and the current opioid abuse epidemic. Oral pain management will be discussed with particular emphasis on the appropriate steps in prescribing oral pain medications.
This two hour course meets the April 1, 2022 Indiana renewal requirement that all optometrists who hold or apply for a controlled substances registration after July 1, 2019 must have completed two hours of continuing education during the previous two years addressing the topic of opioid prescribing and opioid abuse. All optometrists may take the course to meet the requirements for Legend Drug Certificate and license renewal. This course is eligible for 2 hours of IOB and Legend Drug Credit. Course Instructor: Blair Lonsberry, OD